Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS) Damage
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Sheba Medical Center.
Recruitment status was Not yet recruiting
Information provided by (Responsible Party):
Dr. Ofer Keren, Sheba Medical Center
First received: July 4, 2010
Last updated: October 17, 2011
Last verified: October 2011
The goal of the present study is to look at the effect of changing walking parameters on the dynamic walking characteristics among children post severe traumatic brain injury, and typically developed controls.
Other: gait evaluation
||Time Perspective: Cross-Sectional
||Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS)
| Estimated Enrollment:
| Study Start Date:
Other: gait evaluation
The children will asked to walk under different conditions: (1) walking at a self-selected speed faster and slower on the GAITRite® system and on a treadmill and while listening and to a metronomeQuoting.
|Ages Eligible for Study:
||8 Years to 13 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Fifteen children post-TBI and fifteen typically control.
- post-severe closed head injury (Glasgow Coma Scale [GCS] score at admission to emergency room of ≤8) [Kathryn 2008].
- at least one year post trauma.
- ages 7 to 13 years.
- independent ambulation (foot orthoses permitted).
- had received botulinum toxin for spasticity management or had undergone orthopedic surgery in the past six months.
- unable to follow simple instructions.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
ClinicalTrials.gov processed this record on October 22, 2014
||Dr. Ofer Keren, MD, Sheba Medical Center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 4, 2010
||October 17, 2011
||Israel: Israeli Health Ministry Pharmaceutical Administration